NasdaqCM - Nasdaq Real Time Price USD
60 Degrees Pharmaceuticals, Inc. (SXTP)
2.6700
-0.4900
(-15.51%)
At close: 4:00:01 PM EDT
2.7800
+0.11
+(4.12%)
After hours: 6:39:48 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ALLEN CHARLES W Director | Conversion of Exercise of derivative security | May 16, 2024 | 14,000 |
| DOW GEOFFREY S Chief Executive Officer | Stock Award(Grant) | Jan 17, 2025 | 164,570 |
| FIELD PAUL Director | Conversion of Exercise of derivative security | May 16, 2024 | 14,000 |
| KNIGHT THERAPEUTICS, INC. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Jul 28, 2023 | -- |
| MILLER TYRONE Chief Financial Officer | Stock Award(Grant) | Jan 17, 2025 | 26,370 |
| TOOVEY STEPHEN Director | Stock Award(Grant) | May 16, 2024 | 14,000 |
| XU CHERYL Director | Purchase | Dec 16, 2024 | 54,078 |
Related Tickers
ARTL Artelo Biosciences, Inc.
1.1600
+20.77%
PRTG Portage Biotech Inc.
9.86
+8.47%
PHIO Phio Pharmaceuticals Corp.
2.5100
-11.31%
APVO Aptevo Therapeutics Inc.
0.6934
+9.08%
ZVSA ZyVersa Therapeutics, Inc.
0.6650
-5.00%
KTTA Pasithea Therapeutics Corp.
1.5400
+7.69%
CHRO Channel Therapeutics Corporation
1.5500
+8.39%
THTX Theratechnologies Inc.
2.7300
+7.06%
NLSP NLS Pharmaceutics AG
1.4300
-2.72%
DWTX Dogwood Therapeutics, Inc.
5.46
+1.68%